rs61729710

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001378609.3(OTOGL):​c.5227T>A​(p.Leu1743Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000623 in 1,595,370 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 1 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.633

Publications

1 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009636909).
BP6
Variant 12-80342124-T-A is Benign according to our data. Variant chr12-80342124-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226953.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00329 (501/152300) while in subpopulation AFR AF = 0.0114 (473/41564). AF 95% confidence interval is 0.0105. There are 3 homozygotes in GnomAd4. There are 234 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.5227T>A p.Leu1743Ile missense_variant Exon 44 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.5227T>A p.Leu1743Ile missense_variant Exon 44 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5
OTOGLENST00000646859.1 linkc.5092T>A p.Leu1698Ile missense_variant Exon 48 of 63 ENSP00000496036.1 A0A2R8YF04
OTOGLENST00000298820.7 linkc.526T>A p.Leu176Ile missense_variant Exon 5 of 18 5 ENSP00000298820.3 H7BXL6

Frequencies

GnomAD3 genomes
AF:
0.00328
AC:
499
AN:
152182
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0114
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000833
AC:
180
AN:
216076
AF XY:
0.000714
show subpopulations
Gnomad AFR exome
AF:
0.0111
Gnomad AMR exome
AF:
0.000547
Gnomad ASJ exome
AF:
0.000107
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000493
Gnomad NFE exome
AF:
0.0000854
Gnomad OTH exome
AF:
0.000551
GnomAD4 exome
AF:
0.000342
AC:
493
AN:
1443070
Hom.:
1
Cov.:
32
AF XY:
0.000321
AC XY:
230
AN XY:
715812
show subpopulations
African (AFR)
AF:
0.00915
AC:
304
AN:
33238
American (AMR)
AF:
0.000712
AC:
30
AN:
42116
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25688
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39194
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83050
European-Finnish (FIN)
AF:
0.000209
AC:
11
AN:
52518
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5746
European-Non Finnish (NFE)
AF:
0.000103
AC:
113
AN:
1101800
Other (OTH)
AF:
0.000553
AC:
33
AN:
59720
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00329
AC:
501
AN:
152300
Hom.:
3
Cov.:
32
AF XY:
0.00314
AC XY:
234
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0114
AC:
473
AN:
41564
American (AMR)
AF:
0.00118
AC:
18
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
24
47
71
94
118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000536
Hom.:
1
Bravo
AF:
0.00361
ESP6500AA
AF:
0.0101
AC:
37
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000987
AC:
119
Asia WGS
AF:
0.000289
AC:
1
AN:
3472

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

OTOGL: BS1, BS2 -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu1734Ile in exon 43 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 1.0% (37/3654) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs61729710). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
13
DANN
Uncertain
0.99
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.70
T;.;T
MetaRNN
Benign
0.0096
T;T;T
MetaSVM
Benign
-0.61
T
PhyloP100
0.63
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.5
.;.;N
REVEL
Uncertain
0.39
Sift
Benign
0.26
.;.;T
Sift4G
Uncertain
0.022
.;.;D
Vest4
0.42
MVP
0.36
MPC
0.18
ClinPred
0.013
T
GERP RS
2.6
gMVP
0.47
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61729710; hg19: chr12-80735904; API